HRS-4508

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HRS-4508, covering 2024-09-19 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]